Implantica AG (OSTO:IMP A SDB) EBITDA Margin % : 0.00% (As of . 20)

View and export this data going back to 2020. Start your Free Trial

What is Implantica AG EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Implantica AG's EBITDA for the six months ended in . 20 was kr0.00 Mil. Implantica AG's Revenue for the six months ended in . 20 was kr0.00 Mil. Therefore, Implantica AG's EBITDA margin for the quarter that ended in . 20 was 0.00%.

Implantica AG EBITDA Margin % Historical Data

The historical data trend for Implantica AG's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Implantica AG EBITDA Margin % Chart

Implantica AG Annual Data

Trend

EBITDA Margin %

Implantica AG Semi-Annual Data

EBITDA Margin %

Competitive Comparison of Implantica AG's EBITDA Margin %

For the Medical Devices subindustry, Implantica AG's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Implantica AG's EBITDA Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Implantica AG's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Implantica AG's EBITDA Margin % falls into.

Save Embed

;

Save Embed

;

Implantica AG EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Implantica AG's EBITDA Margin % for the fiscal year that ended in . 20 is calculated as

EBITDA Margin %	=	EBITDA (A: . 20 )	/	Revenue (A: . 20 )
	=		/
	=	%

Implantica AG's EBITDA Margin % for the quarter that ended in . 20 is calculated as

EBITDA Margin %	=	EBITDA (Q: . 20 )	/	Revenue (Q: . 20 )
	=		/
	=	%

Implantica AG (OSTO:IMP A SDB) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Implantica AG EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Implantica AG's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Implantica AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Implantica AG (OSTO:IMP A SDB) » Definitions » EBITDA Margin %

Comparable Companies

Traded in Other Exchanges

8IM1:Germany

Address

Aeulestrasse 45, Vaduz, LIE, 9490

Website

https://www.implantica.com

Implantica AG is a medtech group providing effective care for serious health conditions and improving patients' quality of life by bringing advanced technology into the body. The therapies Implantica develops are based on implants that are medical devices inserted into the patient's body and are intended to remain in place permanently or semi-permanently, using electrical power provided by a battery. The company has developed a broad, patent-protected, product pipeline based partly on its two platform technologies. To bring advanced technology into the body, and adequate energy supply is required which would require very large batteries, so, Implantica has developed a wireless energising platform to supply energy to the body through intact skin.

Implantica AG Headlines

No Headlines